12:00 AM
 | 
May 25, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

EndoTAG-1 regulatory update

FDA granted Orphan Drug designation for MediGene's EndoTAG-1 to treat pancreatic cancer. The IV...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >